Jeffrey Weber on the Role of Oncology Nurses in Treating Patients With Checkpoint Inhibitors
September 8th 2016Jeffrey Weber, MD, PhD, deputy director of the Perlmutter Cancer Center, NYU Langone Medical Center, discusses the role of the oncology nurse when treating patients who have cancer with checkpoint inhibitors.
Moving Proactively to Support Patients With EGFR Inhibitor-Related Dermatologic AEs
May 1st 2016Developing a skin rash as a result of EGFR-inhibitor targeted therapy often signals that the drug is working, but for patients who experience these serious dermatologic adverse events, it may become so intolerable that they will scale back or even discontinue anticancer medications that could prolong their survival.
Sancy Leachman on Patients at High Risk for Melanoma
January 16th 2016Sancy Leachman, MD, PhD, professor and chair, Department of Dermatology, director, Melanoma Research Program, Knight Cancer Institute, Oregon Health & Science University, discusses patients who are at high risk for developing melanoma.
Sancy Leachman on Monitoring for Melanoma Recurrences
December 28th 2015Sancy Leachman, MD, PhD, professor and chair, Department of Dermatology, director, Melanoma Research Program, Knight Cancer Institute, Oregon Health & Science University, discusses how a mobile app can help oncology professionals monitor patients for melanoma.